期刊文献+

妊娠期高血压疾病风险预测模型建立探讨 被引量:18

Establishment of Risk Prediction Model of Hypertensive Disorders in Pregnancy
下载PDF
导出
摘要 目的:探讨妊娠期高血压疾病(HDP)的危险因素,建立HDP风险预测模型。方法:回顾性分析四川省妇幼保健院8771例孕妇的HDP风险因素及早中孕期特异性血清学指标,筛选207例HDP孕妇作为HDP组,4556例孕妇作为对照组。比较两组病例间的风险因素及特异性血清学指标的差异性,建立HDP风险预测模型。结果:(1)两组孕妇的孕前BMI、预产期年龄、产次、β-人绒毛膜促性腺激素(β-hCG)、妊娠相关蛋白(PAPP-A)的差异有统计学意义(P<0.005);而甲胎蛋白(AFP)、抑制素A(Inhibin A)的差异无统计学意义(P>0.05);(2)当联合β-hCG+PAPP-A+孕前BMI+预产期年龄+产次联合建立HDP风险预测模型时,最大约登指数为0.816,对应敏感度为0.875,特异度为0.941,AUC为0.907;联合β-hCG+PAPP-A+AFP+Inhibin A+孕前BMI+预产期年龄+产次联合建立HDP风险预测模型时,其最大约登指数为0.926,对应敏感度为0.926,特异度为1,AUC为0.968。结论:联合β-hCG+PAPP-A+孕前BMI+预产期年龄+产次联合建立的HDP风险预测模型具有较高的预测价值及临床意义;而AFP、Inhibin A作为预测指标联合建立HDP风险预测模型的价值还需进一步认证。 Objective:To explore the risk factors of hypertensive disorders of pergnancy(HDP)and establish a risk prediction model of HDP.Methods:The risk factors of HDP in 8771 pregnant women in Sichuan Maternal and Child Health Hospital were analyzed retrospectively.The specific serological indexes in the first and second trimester were selected.207 pregnant women were selected as the HDP group and 4556 pregnant women were selected as the control group.The differences of risk factors and specific serological indexes between the two groups were compared,and the HDP risk prediction model was established.Results:(1)The differences in pre-pregnancy BMI,expected age,parity,β-hCG,and PAPP-A between the two groups were statistically significant(P<0.005),while the differences in AFP and Inhibin A were not statistically significant(P>0.05).(2)When β-hCG+PAPP-A+pre-pregnancy BMI+expected age+parity werecombined to establish an HDP prediction model,the maximum Youden index was 0.816,the corresponding sensitivity was 0.875,the specificity was 0.941,and the AUC value was 0.907,while combining β-hCG+PAPP-A+AFP+Inhibin A+pre-pregnancy BMI+expected age+parity to establish the HDP prediction model,the maximum Youden index was 0.926,the corresponding sensitivity was 0.926,the specificity was 1,and the AUC value was 0.968.Conclusions:The HDP risk prediction model established by β-hCG+PAPP-A+pre-pregnancy BMI+expected age+parityhas high prediction value and clinical significance.While the value of AFP and Inhibin A as the predictors to jointly establish the HDP risk prediction model still needs be further investigation.
作者 钟文 王璇 漆洪波 杜晓红 聂小成 唐丽娟 梁羽 刘谢芹 敖丽 高岩 ZHONG Wen;WANG Xuan;QI Hongbo(Department of Obstetrics,Sichuan Maternal and Child Health Hospital,Chengdu Sichuan 610041,China;Department of Obstetrics,Chongqing Health Center for Women and Children,Chongqing 401120,China)
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2022年第3期228-232,共5页 Journal of Practical Obstetrics and Gynecology
关键词 妊娠期高血压疾病 早中孕期血清学指标 一般临床特征 预测 Hypertensive disorders of pregnancy Serological indicators of first and second trimester General clinical characteristics Prediction
  • 相关文献

参考文献1

二级参考文献36

  • 1American College of Obstetricians and Gynecologists;Task Force on Hypertension in Pregnancy.Hypertension in pregnancy.Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy[J].Obstet Gynecol,2013,122(5):1122-1131.DOI:10.1097/01.AOG.0000437382.03963.88.
  • 2Magee LA,Pels A,Helewa M,et al.Canadian Hypertensive Disorders of Pregnancy Working Group.Diagnosis,evaluation,and management of the hypertensive disorders of pregnancy:executive summary[J].J Obstet Gynaecol Can,2014,36(5):416 441.
  • 3Visintin C,Mugglestone MA,Almerie MQ,et al.Management of hypertensive disorders during pregnancy:summary of NICE guidance[J].BMJ,2010,341:c2207.DOI:10.1136/bmj.c2207.
  • 4Lowe SA,Bowyer L,Lust K,et al.The SOMANZ Guidelines for the Management of Hypertensive Disorders of Pregnancy 2014[J].Aust N Z J Obstet Gynaecol,2015,55(1):11-16.DOI:10.1111/ajo.12253.
  • 5Campos-Outcalt D Sr.US Preventive Services Task Force:the gold standard of evidence-based prevention[J].J Fam Pract,2005,54(6):517-519.
  • 6Magee LA,Helewa M,Moutquin JM,et al.Diagnosis,evaluation,and management of the hypertensive disorders of pregnancy[J].J Obstet Gynaceol Can,2008,30(3 Suppl):S 1-48.
  • 7C(o)té AM,Brown MA,Lam E,et al.Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women:systematic review[J].BMJ,2008,336(7651):1003-1006.DOI:10.1136/bmj.39532.543947.BE.
  • 8Churchill D,Beevers GD,Meher S,et al.Diuretics for preventing pre-eclampsia[J].Cochrane Database Syst Rev,2007(1):CD004451.
  • 9McCoy S,Baldwin K.Pharmacotherapeutic options for the treatment of preeclampsia[J].Am J Health Syst Pharm,2009,66(4):337-344.DOI:10.2146/ajhp080104.
  • 10Duley L,Gülmezoglu AM,Chou D.Magnesium sulphate versus lytic cocktail for eclampsia[J].Cochrane Database Syst Rev,2010(9):CD002960.DOI:10.1002/14651858.CD002960.pub2.

共引文献263

同被引文献156

引证文献18

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部